175 related articles for article (PubMed ID: 25560489)
1. p21-Activated kinase 5 affects cisplatin-induced apoptosis and proliferation in hepatocellular carcinoma cells.
Zhang DG; Zhang J; Mao LL; Wu JX; Cao WJ; Zheng JN; Pei DS
Tumour Biol; 2015 May; 36(5):3685-91. PubMed ID: 25560489
[TBL] [Abstract][Full Text] [Related]
2. p21-activated kinase 5 inhibits camptothecin-induced apoptosis in colorectal carcinoma cells.
Wang X; Gong W; Qing H; Geng Y; Wang X; Zhang Y; Peng L; Zhang H; Jiang B
Tumour Biol; 2010 Dec; 31(6):575-82. PubMed ID: 20567954
[TBL] [Abstract][Full Text] [Related]
3. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
Zhai J; Qu S; Li X; Zhong J; Chen X; Qu Z; Wu D
Biochem Biophys Res Commun; 2015 Aug; 464(1):161-7. PubMed ID: 26116538
[TBL] [Abstract][Full Text] [Related]
4. An oncogenic kinase: putting PAK5 forward.
Wen YY; Zheng JN; Pei DS
Expert Opin Ther Targets; 2014 Jul; 18(7):807-15. PubMed ID: 24869804
[TBL] [Abstract][Full Text] [Related]
5. Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis.
Liu FY; Wu YH; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Huang ZY
Oncol Rep; 2014 Aug; 32(2):835-44. PubMed ID: 24919588
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
[TBL] [Abstract][Full Text] [Related]
7. PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell.
Wang XX; Cheng Q; Zhang SN; Qian HY; Wu JX; Tian H; Pei DS; Zheng JN
Tumour Biol; 2013 Oct; 34(5):2721-9. PubMed ID: 23696025
[TBL] [Abstract][Full Text] [Related]
8. Rottlerin upregulates DDX3 expression in hepatocellular carcinoma.
Wang Z; Shen GH; Xie JM; Li B; Gao QG
Biochem Biophys Res Commun; 2018 Jan; 495(1):1503-1509. PubMed ID: 29203243
[TBL] [Abstract][Full Text] [Related]
9. P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma.
Fang ZP; Jiang BG; Gu XF; Zhao B; Ge RL; Zhang FB
Acta Pharmacol Sin; 2014 Jan; 35(1):82-8. PubMed ID: 23685956
[TBL] [Abstract][Full Text] [Related]
10. The Ethanolic Extract of Taiwanofungus camphoratus (Antrodia camphorata) Induces Cell Cycle Arrest and Enhances Cytotoxicity of Cisplatin and Doxorubicin on Human Hepatocellular Carcinoma Cells.
Lin LT; Tai CJ; Su CH; Chang FM; Choong CY; Wang CK; Tai CJ
Biomed Res Int; 2015; 2015():415269. PubMed ID: 26557666
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
12. The overexpression of P21-activated kinase 5 (PAK5) promotes paclitaxel-chemoresistance of epithelial ovarian cancer.
Li D; Yao X; Zhang P
Mol Cell Biochem; 2013 Nov; 383(1-2):191-9. PubMed ID: 23877225
[TBL] [Abstract][Full Text] [Related]
13. p21-Activated kinase 5: a pleiotropic kinase.
Wen YY; Wang XX; Pei DS; Zheng JN
Bioorg Med Chem Lett; 2013 Dec; 23(24):6636-9. PubMed ID: 24215894
[TBL] [Abstract][Full Text] [Related]
14. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
Huo S; Yu H; Li C; Zhang J; Liu T
Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway.
Han ZX; Wang XX; Zhang SN; Wu JX; Qian HY; Wen YY; Tian H; Pei DS; Zheng JN
Brain Tumor Pathol; 2014 Oct; 31(4):234-41. PubMed ID: 24062079
[TBL] [Abstract][Full Text] [Related]
16. Silencing of ATG4D suppressed proliferation and enhanced cisplatin-induced apoptosis in hepatocellular carcinoma through Akt/Caspase-3 pathway.
Zhao JY; Li XY; Liu TD; Liang B; Huang Y; Li W
Mol Cell Biochem; 2021 Nov; 476(11):4153-4159. PubMed ID: 34313895
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
18. Synergy of Raddeanin A and cisplatin induced therapeutic effect enhancement in human hepatocellular carcinoma.
Li JN; Yu Y; Zhang YF; Li ZM; Cai GZ; Gong JY
Biochem Biophys Res Commun; 2017 Apr; 485(2):335-341. PubMed ID: 28219642
[TBL] [Abstract][Full Text] [Related]
19. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain.
Pandey A; Dan I; Kristiansen TZ; Watanabe NM; Voldby J; Kajikawa E; Khosravi-Far R; Blagoev B; Mann M
Oncogene; 2002 May; 21(24):3939-48. PubMed ID: 12032833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]